Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Ethereum Tops This Key Level; Axie Infinity Emerges As Top Gainer

Bitcoin (CRYPTO: BTC) moved higher, with the cryptocurrency prices trading above the $34,600 level on Monday. Ethereum (CRYPTO: ETH) also recorded gains, trading above the key $1,800 mark this morning.
byLisa Levin
October 30, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Bitcoin (CRYPTO: BTC) moved higher, with the cryptocurrency prices trading above the $34,600 level on Monday.

Ethereum (CRYPTO: ETH) also recorded gains, trading above the key $1,800 mark this morning.

Axie Infinity (CRYPTO: AXS) was the top gainer over the prior 24 hours, while Injective (CRYPTO: INJ) turned out to be the biggest loser.

At the time of writing, the global crypto market cap rose to $1.28 trillion, recording a 24-hour gain of 1.1%. BTC was trading higher by 1.1% at $34,642 while ETH rose by around 1.3% to $1,815 on Monday.

Here are the top ten crypto gainers and losers over the past 24 hours:

Gainers

 

Axie Infinity (CRYPTO: AXS)
Price: $5.78
24-hour gain: 15.1%

Gala (CRYPTO: GALA)
Price: $0.02071
24-hour gain: 14.1%

Solana (CRYPTO: SOL)
Price: $34.95
24-hour gain: 8.1%

The Sandbox (CRYPTO: SAND)
Price: $0.3574
24-hour gain: 7.8%

Decentraland (CRYPTO: MANA)
Price: $0.3784
24-hour gain: 7.4%

Losers

 

Injective (CRYPTO: INJ)
Price: $13.84
24-hour drop: 2.2%

Stacks (CRYPTO: STX)
Price: $0.636
24-hour drop: 1.6%

Maker (CRYPTO: MKR)
Price: $1,418
24-hour drop: 1.5%

UNUS SED LEO (CRYPTO: LEO)
Price: $3.94
24-hour drop: 0.9%

EOS (CRYPTO: EOS)
Price: $0.6257
24-hour drop: 0.6%

Read This Next: Insiders Buying M&T Bank And 3 Other Stocks

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cerevel Reports Results In Emraclidine Ambulatory Blood Pressure Monitoring Trial; Co. Reports ‘Data provide clear evidence that emraclidine does not induce an increase in blood pressure with chronic dosing in people living with schizophrenia’

By Benzinga Newsdesk
December 19, 7:32 AM
Data provide clear evidence that emraclidine does not induce an increase in blood pressure with chronic dosing in people living with schizophrenia Emraclidine demonstrated a mean change from baseline in 24-hour

CERE

Read More

Here’s How To Enhance Marijuana Therapies: KindlyMD And Curaleaf Collab Provide More Resources And Information To Utah Patients

By Jelena Martinovic
June 10, 1:51 PM
Healthcare data company KindlyMD, Inc. (NASDAQ: KDLY) has teamed up with the U.S. cannabis giant Curaleaf Holdings, Inc. (TSX: CURA)(OTCQX: CURLF) to provide educational resources and information with a community perspective on holistic pain management and treatment. KindlyMD said its providers will debut the KindlyMD Complete Care program, under which patients in Utah County and its surrounding areas would have the option to more easily access the medical cannabis care options offered by Curaleaf pharmacists.Tim Pickett, PA-C, founder and CEO at KindlyMD, said the goal of the new collaboration with CUraleaf is addressing the issue of the nation's opioid crisis and "negative impacts of addiction and overdose."

CURLF